Spleen tyrosine kinase (Syk) as a therapeutic target in antibody-dependent transplant rejection. [ 2014 - 2016 ]

Research Grant

Researchers: A/Pr David Nikolic-Paterson (Principal investigator) ,  A/Pr John Kanellis ,  Dr Frank Ma

Brief description While kidney transplantation is a life saving treatment for those with end-stage kidney failure, a significant number of patients face long waits on dialysis because they have antibodies that would cause rejection of most potential donor kidneys. This project seeks to address this problem using a new strategy to treat antibody-mediated rejection and thereby enable such patients to receive a transplant without the fear of severe rejection.

Funding Amount $AUD 625,919.23

Funding Scheme Project Grants

Notes Standard Project Grant